WebJul 29, 2024 · Cytocom intends to draw down the first $15 million within 30 days of the closing of the recently completed merger between Cleveland BioLabs and Cytocom. A combination of debt and equity financing ... WebOct 21, 2024 · Cytocom, Inc. is a leader in immune modulation for the treatment of serious disease is a company developing novel immunotherapies targeting autoimmune, inflammatory, infectious diseases and...
Did you know?
WebOct 21, 2024 · Cytocom, Inc. is a leader in immune modulation for the treatment of serious disease is a company developing novel immunotherapies targeting autoimmune, inflammatory, infectious diseases and cancers based on a proprietary platform designed to rebalance the body's immune system and restore homeostasis. WebAug 5, 2024 · Cytocom Inc. is a clinical-stage biopharmaceutical company developing novel immunotherapies targeting autoimmune, neutropenia/anemia, emerging viruses and cancers based on a proprietary...
WebImQuest Pharmaceuticals was merged into Cytocom’s existing drug development operations, and ImQuest Biosceinces, the contract research organization (CRO), operates as wholly-owned, revenue-generating … WebCytocom Subsidiary Inc. COUNTRY NAME: USA TICKER SYMBOL: STAB EXCHANGE NAME: NASDAQ - - Links on this page: Page Last Updated: 03/08/2024. Note: If you need help accessing information in different file formats, see ...
WebJul 28, 2024 · Cytocom, Inc. is a clinical-stage biopharmaceutical company developing novel immunotherapies targeting autoimmune, inflammatory, infectious diseases and … WebOct 21, 2024 · Cytocom, Inc. is a leader in immune modulation for the treatment of serious disease is a company developing novel immunotherapies targeting autoimmune, inflammatory, infectious diseases and cancers based on a proprietary platform designed to rebalance the body’s immune system and restore homeostasis.
WebIn December 2013, the Company formed a subsidiary, Cytocom Inc. (“Cytocom”), to focus on conducting LDN and MENK clinical trials in the United States. The Company also transferred certain rights to Cytocom, including rights, titles, and interests in or relating to intellectual property, which are further described in the section of ...
WebAug 31, 2024 · Cytocom, Inc. emerged as a publicly-traded entity following the merger between the former Cleveland BioLabs and the formerly private Cytocom Inc., completed on July 27, 2024. “The new corporate name, Statera BioPharma and updated ticker symbol mark the latest event in a transformative year for the company,” said Michael K. Handley, … t t sutherlandWebSep 1, 2024 · Statera Biopharma (formerly Cytocom, Inc.) is a clinical-stage biopharmaceutical company developing novel immunotherapies targeting autoimmune, neutropenia/anemia, emerging viruses and … phoenix vs chicagoWebAug 14, 2014 · Cytocom, Inc. is a biotechnology company that will initially focus on developing LDN (Lodonal™) and MENK in the investigation of unmet medical needs in the areas of oncological and inflammatory... phoenix walk in centre parkfieldsWebJul 20, 2024 · Subsequent to the acquisition closing, ImQuest Pharmaceuticals, the drug development arm of ImQuest Life Sciences, will be merged into Cytocom's existing drug development operations. Meanwhile, ImQuest BioSciences, a contract research organization (CRO), will continue to operate as a separate wholly-owned, revenue-generating … tts wales limitedWebOn June 24, 2024, Cytocom completed the acquisition of ImQuest Life Sciences, Inc. and its subsidiaries (“ImQuest”) in accordance with the Agreement and Plan of Merger by … phoenix waco 60cc manualWebContact Email [email protected]. Phone Number 1-888-629-4155. Cytocom, Inc. a specialty biotech company, founded by patients, specializing in repurposing of drugs that … phoenix walk to end alzheimer\u0027sWebJul 28, 2024 · Cytocom, Inc. is a clinical-stage biopharmaceutical company developing novel immunotherapies targeting autoimmune, inflammatory, infectious diseases and cancers based on a proprietary platform... tts voices torrent